Robert Knowles, PhD


Senior Director, Worldwide Business Development

Robert Knowles, PhD, Senior Director, Worldwide Business Development at Pfizer, has been leading cross-divisional business development teams at Pfizer for 20 years. His recent focus has been due diligence and risk assessment of clinical-stage treatments for metabolic and gastrointestinal diseases.

His transactions have included Pfizer’s co-development collaborations with Merck & Co. on Steglatro (ertugliflozin)/Steglujan (ertugliflozin and sitagliptin) (diabetes) and with Opko Health on somatrogen (growth hormone deficiency), Pfizer’s acquisitions of Anacor (dermatology) and Medivation (oncology), and Pfizer’s recent co-promotion with Exact Sciences for Cologuard (colon cancer screening).

Dr. Knowles’ early research career included a PhD in virology, postdoctoral studies in immunogenetics, a faculty position at Sloan-Kettering, and Head of Immunology Research at Johnson & Johnson.